BRIEF published on 05/28/2026 at 07:05, 5 months 17 days ago MRM Health obtient une subvention de 2,6 millions d'euros du VLAIO pour la recherche sur les maladies inflammatoires Maladies Inflammatoires MRM Santé Subvention VLAIO Recherche Sur Le Microbiome Produits Biothérapeutiques Vivants
BRIEF published on 05/28/2026 at 07:05, 5 months 17 days ago Sanofi's Venglustat Granted Priority Review for Type 3 Gaucher Disease Sanofi FDA Review Venglustat Gaucher Disease Neurological Treatment
BRIEF published on 05/28/2026 at 07:05, 5 months 17 days ago Le venglustat de Sanofi obtient un examen prioritaire pour la maladie de Gaucher de type 3 Sanofi Examen De La FDA Venglustat Maladie De Gaucher Traitement Neurologique
BRIEF published on 05/28/2026 at 07:05, 5 months 17 days ago Le venglustat de Sanofi en examen prioritaire par la FDA pour la maladie de Gaucher de type 3 FDA Sanofi Examen Prioritaire Venglustat Maladie De Gaucher
BRIEF published on 05/28/2026 at 07:05, 5 months 17 days ago Sanofi's venglustat under priority review by the FDA for type 3 Gaucher disease FDA Sanofi Venglustat Gaucher's Disease Priority Examination
BRIEF published on 05/28/2026 at 06:50, 5 months 17 days ago PURE Swiss Opportunity REF Completes Successful Capital Increase Investment Strategy Capital Increase Fund Management Financial Growth Swiss Real Estate
BRIEF published on 05/28/2026 at 06:50, 5 months 17 days ago PURE Swiss Opportunity REF finalise avec succès son augmentation de capital Croissance Financière Augmentation De Capital Stratégie D'investissement Immobilier Suisse Gestion De Fonds
BRIEF published on 05/28/2026 at 06:45, 5 months 17 days ago Galenica Reports Steady Sales Growth Amid Market Challenges Sales Growth Pharmacy Market 2026 Financial Outlook Wholesale Performance Home Care And Diagnostics
BRIEF published on 05/28/2026 at 06:45, 5 months 17 days ago Galenica enregistre une croissance soutenue de ses ventes malgré les difficultés du marché. Croissance Des Ventes Marché Pharmaceutique Perspectives Financières 2026 Performance De Gros Soins À Domicile Et Diagnostics
BRIEF published on 05/28/2026 at 06:45, 5 months 17 days ago Croissance du Chiffre d'Affaires de Galenica Malgré un Marché Exigeant Croissance Financière Soins À Domicile Marché Pharmaceutique Galenica AG Commerce De Gros
Published on 11/14/2026 at 01:30, 7 hours 23 minutes ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 8 hours 13 minutes ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 8 hours 18 minutes ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 8 hours 53 minutes ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:15, 9 hours 38 minutes ago Core Critical Metals Corp. Announces $500,000 Non-Brokered Critical Mineral Flow-Through Private Placement
Published on 11/13/2026 at 23:24, 9 hours 29 minutes ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 11 hours 1 minute ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 13 hours 44 minutes ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 13 hours 53 minutes ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 11:35, 21 hours 18 minutes ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 21 hours 18 minutes ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 1 day ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 1 day 9 hours ago Belgrano continues the implementation of its public share buyback offer (OPRA)
